Increase public health messaging to encourage COVID-19 booster uptake and counter misinformation.
Pandemics
Pandemics Risk
Assessment for this date
Today's pandemic risk is moderate due to rising COVID-19 activity, ongoing avian flu cases, and persistent challenges in vaccine uptake and misinformation.
August 19, 2025
Trend
Viewing the record for August 19, 2025 within the full trend.
Risk Drivers
What is pushing the current reading.
The current pandemic risk is heightened by an increase in COVID-19 activity in the US, concerns about long COVID, and the potential for reinfection to exacerbate symptoms. Meanwhile, avian flu cases are being reported in multiple countries, including human infections in Cambodia, which could indicate a risk of wider spread. Vaccine uptake remains a challenge, with a significant portion of the population planning to skip COVID boosters, and misinformation continues to undermine public health efforts. These factors, combined with the ongoing threat of other infectious diseases like MERS and chikungunya, contribute to a moderate risk level, with potential for escalation if containment and vaccination efforts are not effectively managed.
Risk Reduction Actions
Priority actions generated from the current analysis.
Enhance surveillance and reporting of avian flu cases to prevent potential outbreaks.
Support research and development of vaccines for emerging infectious diseases like MERS and chikungunya.
Strengthen international collaboration to monitor and respond to cross-border disease threats.
Engage local communities to build trust in vaccines and public health measures.
Sources Monitored
Visible feeds used in this category's nightly run.
Selected Articles
Supporting articles referenced in the latest score.
- US COVID activity gains more steam
- Cambodia announces 15th human H5N1 infection of the year
- Saudi Arabia confirms 9 MERS cases, including hospital cluster
- Global leaders stress importance of broad-based, cooperative research to be ready for next pandemic
- Poll finds false measles claims gaining attention amid US outbreaks